Press Release
10 |
Nov 2015 |
IntelGenx and RedHill Biopharma Announce First European Marketing Approval of RIZAPORT(TM) for Migraines... |
04 |
Nov 2015 |
IntelGenx Reports Record Third Quarter 2015 Financial Results... |
29 |
Oct 2015 |
IntelGenx to Report Third Quarter 2015 Financial Results on November 3, 2015... |
17 |
Sep 2015 |
IntelGenx to Present at the Singular Research 10th Annual “Best Of The Uncovereds” Global Investment Conference... |
09 |
Sep 2015 |
IntelGenx Corp. and RedHill Biopharma Ltd Announce Positive Outcome of the Decentralized Procedure for Approval of RIZAP... |
31 |
Aug 2015 |
IntelGenx to Present at the 17th Annual Rodman & Renshaw Global Investment Conference... |
10 |
Aug 2015 |
IntelGenx Reports Q2 and First Six Months 2015 Results and Provides Corporate Development Update... |
06 |
Aug 2015 |
IntelGenx to Provide Second Quarter 2015 Update on August 10, 2015... |
05 |
Aug 2015 |
IntelGenx Announces Appointment of New Director... |
20 |
Jul 2015 |
IntelGenx Appoints André Godin as New Executive Vice-President and Chief Financial Officer... |
14 |
May 2015 |
IntelGenx Reports Q1, 2015 Results and Provides Corporate Development Update... |
13 |
May 2015 |
IntelGenx Announces Management Changes... |
05 |
May 2015 |
IntelGenx Confirms Execution of Lease and Construction Agreements... |
04 |
May 2015 |
IntelGenx to Report 2015 First Quarter Update Call on May 15, 2015... |
22 |
Apr 2015 |
IntelGenx Provides Q1, 2015 Update on Sales of Forfivo XL(R)... |
16 |
Apr 2015 |
IntelGenx Announces Analyst Coverage Initiated by Singular Research... |
10 |
Apr 2015 |
IntelGenx Founder, President and CEO Dr. Horst Zerbe Interviewed on Fox Business Network's "After the Bell"... |
31 |
Mar 2015 |
IntelGenx Reports 2014 Annual Results and Provides Corporate Development Update... |
23 |
Mar 2015 |
IntelGenx to Report 2014 Annual Results and Provide Corporate Development Update on March 31, 2015... |
24 |
Feb 2015 |
IntelGenx Provides Update on Sales of Forfivo XL(R)... |